The stock market, like any other industry, is riddled with clichés. One of the most commonly used is the ubiquitous “buy the rumor, sell the news.” However, clichés are not clichés without reason (another cliché...) and the old maxim could perfectly describe last week’s performance of Atossa Therapeutics (ATOS) stock. Since the end of April, shares had more than tripled in anticipation of the final results from the phase 2 clinical trial evaluating oral endoxifen, the biotech’s breast cancer treatment to be administered between diagnosis and surgery. The company disclosed the results last week. With a 65.
https://www.tipranks.com/news/article/time-to-load-up-on-atossa-shares-this-analyst-thinks-so
Atossa Therapeutics (NASDAQ:ATOS)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Atossa Therapeutics Charts.
Atossa Therapeutics (NASDAQ:ATOS)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Atossa Therapeutics Charts.